Clinical trial
BELgian ANtiCOagulation Survey for NVAF Patients
NCT04183270 is registered in ClinicalTrials.gov with Bayer as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- BELgian ANtiCOagulation Survey for NVAF Patients
- Lead sponsor
- Bayer
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 10, 2020
- Completion date
- December 31, 2020
- Enrollment
- 164 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.